Lv12
44 积分 2023-12-13 加入
Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial
16分钟前
待确认
Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial
2小时前
已完结
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
1天前
已完结
Two-year outcomes post-discharge in Asian patients with acute coronary syndrome: Findings from the EPICOR Asia study
1个月前
已完结
The pharmacokinetics and comparative bioavailabilty of oral and subcutaneous semaglutide in healthy volunteers
1个月前
已完结
The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma
1个月前
已完结
Non-peptide, once-per-day oral orforglipron to compete with established peptide-based, injectable GLP-1 receptor agonists
1个月前
已完结
The G Protein-First Mechanism for Activation of the Class B Glucagon-like Peptide 1 Receptor Coupled to N-Terminal Domain-Mediated Conformational Progression
1个月前
已完结
Type 2 diabetes
1个月前
已完结
Type 2 diabetes
1个月前
已完结
皖公网安备34019202002308
